Evolus sells Jeuveau and Evolysse injectable aesthetic treatments to licensed aesthetic practitioners. It last closed at $6.69 on Nov 17, up 0.90% on the day. The average 12-month price target from 2 analysts is $14.00 (+109.3% from the last close), with a high of $15.00 and a low of $13.00.
Only 2 firms rated EOLS in the past 90 days, not enough for a consensus
Average 12-month target
$14.00
▲ 109.3% upside
Based on 2 analysts who set a price target on EOLS in the past 90 days. The average target is $14.00, with a high of $15.00 and a low of $13.00, compared with the last close of $6.69.
Low $13.00Avg $14.00High $15.00
Blue marker: last close $6.69
Highest target$15.00
Average target$14.00
Lowest target$13.00
Latest rating changes
BTIGTarget raised
Nov 5Buy$13 → $15
HC Wainwright & Co.Reiterated
Aug 25Buy$13
BTIGReiterated
Jun 17Buy$13
Date
Firm
Action
Rating
Price target
Nov 5
BTIG
Target raised
Buy
$13 → $15
Aug 25
HC Wainwright & Co.
Reiterated
Buy
$13
Jun 17
BTIG
Reiterated
Buy
$13
Loading…
Technical Analysis
EOLS · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend
The stock is 7% below its 20 day and 12% below its 50 day average. It is 5% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the Pivot at $6.57, and the nearest resistance the swing high (May 28) at $6.76.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 6.1%/day
Key levels
$9.3152 week high+39.2%
$7.5250 day average+12.4%
$7.41100 day average+10.8%
$7.1620 day average+7.0%
$6.85Pivot R1+2.4%
$6.76Swing high (May 28)+1.0%
$6.69Last close
$6.57Pivot−1.8%
$6.47Swing low (Jun 11)−3.3%
$6.42Pivot S1−4.0%
$6.39200 day average−4.5%
$3.8652 week low−42.3%
Indicators
RSI (14)
41.01
Middle of its range
Neutral
MACD
-0.20
Below its signal line
Bearish
Stochastic
26.5
Middle of its range
Neutral
ADX (14)
14.8
No clear trend
Williams %R
-74.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-151.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−9.2%
Change over 10 sessions
Bearish
ATR (14)
$0.41
Typical daily range, 6.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Moving sideways
Short trendNeutral
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityNormal, 13.4%/day
Key levels
$9.3152 week high+39.2%
$7.5250 day average+12.4%
$7.41100 day average+10.8%
$7.1620 day average+7.0%
$6.85Pivot R1+2.4%
$6.76Swing high (May 28)+1.0%
$6.69Last close
$6.57Pivot−1.8%
$6.47Swing low (Jun 11)−3.3%
$6.42Pivot S1−4.0%
$6.39200 day average−4.5%
$3.8652 week low−42.3%
Indicators
RSI (14)
46.77
Middle of its range
Neutral
MACD
0.13
Below its signal line
Bearish
Stochastic
19.9
Near the bottom of its range
Oversold
ADX (14)
15.8
No clear trend
Williams %R
-87.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-67.9
Oversold below −100, overbought above 100
Neutral
Rate of change
−14.7%
Change over 10 sessions
Bearish
ATR (14)
$0.90
Typical daily range, 13.4% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Below
MA 200–
What happened before, for EOLS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how EOLS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow EOLS usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How EOLS has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether EOLS is in one of them and how their past EOLS trades turned out.
Evolus is a medical aesthetics company based in Newport Beach, California. It sells Jeuveau, an injectable botulinum toxin used to smooth frown lines, and Evolysse, a line of injectable hyaluronic acid gels used for wrinkles, folds, and facial volume. Its customers are licensed aesthetic practitioners, and patients generally pay for these treatments directly out of pocket rather than through insurance. The company relies on outside manufacturers in South Korea and France to produce its products.